Bank Of New York Mellon Corp Clearside Biomedical, Inc. Transaction History

Bank Of New York Mellon Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.93 - $1.66 $27,452 - $49,001	29,519 New	29,519 $30.7 Million
Q4 2022 Feb 14, 2023	BUY	$1.0 - $1.5 $29,519 - $44,278	29,519 New	29,519 $33,000
Q2 2022 Aug 15, 2022	SELL	$1.3 - $2.49 $1,658 - $3,177	-1,276 Reduced 4.14%	29,519 $43,000
Q3 2021 Nov 12, 2021	BUY	$4.83 - $7.2 $56,472 - $84,182	11,692 Added 61.21%	30,795 $185,000
Q1 2021 May 13, 2021	SELL	$2.24 - $4.25 $4,269 - $8,100	-1,906 Reduced 9.07%	19,103 $47,000
Q3 2019 Nov 07, 2019	SELL	$0.59 - $1.32 $16,068 - $35,948	-27,234 Reduced 56.45%	21,009 $13,000
Q2 2019 Aug 12, 2019	SELL	$0.97 - $1.42 $60,195 - $88,120	-62,057 Reduced 56.26%	48,243 $47,000
Q1 2019 May 14, 2019	SELL	$1.1 - $1.74 $1,837 - $2,905	-1,670 Reduced 1.49%	110,300 $152,000
Q4 2018 Feb 11, 2019	BUY	$1.0 - $6.12 $27,652 - $169,230	27,652 Added 32.79%	111,970 $120,000
Q3 2018 Nov 09, 2018	BUY	$6.03 - $11.24 $22,901 - $42,689	3,798 Added 4.72%	84,318 $0
Q2 2018 Aug 06, 2018	SELL	$8.91 - $14.54 $608,339 - $992,733	-68,276 Reduced 45.89%	80,520 $861,000
Q1 2018 May 15, 2018	BUY	$5.57 - $14.28 $323,477 - $829,311	58,075 Added 64.01%	148,796 $1.6 Million
Q4 2017 Feb 09, 2018	BUY	$5.78 - $9.12 $524,367 - $827,375	90,721	90,721 $636,000

13.4M

17.6K

100

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $61.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.